(Q79175432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14563418%20AND%20SRC:MED&resulttype=core&format=json

reason for deprecated rank

20 December 2019

title

Le virus GB-C ou virus « dit » de l’hépatite G est-il impliqué en pathologie humaine ? (French)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1016/S1246-7820(03)00095-8

reason for deprecated rank

22 March 2024

Is GB virus C alias "hepatitis" G virus involved in human pathology? (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563418

22 March 2024

GB virus C

1 reference

V. Chams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563418

22 March 2024

C. Fournier-Wirth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563418

22 March 2024

A. Chabanel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563418

22 March 2024

P. Hervé

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563418

22 March 2024

C. Trépo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563418

22 March 2024

language of work or name

French

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14563418

22 March 2024

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14563418%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

https://api.elsevier.com/content/article/PII:S1246782003000958?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1246-7820(03)00095-8

https://api.elsevier.com/content/article/PII:S1246782003000958?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1246-7820(03)00095-8

Transfusion Clinique et Biologique

22 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14563418%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14563418%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14563418%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

292-306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14563418%20AND%20SRC:MED&resulttype=core&format=json

Isolation of novel virus-like sequences associated with human hepatitis

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Phylogenetic analysis of GB viruses A and C: evidence for cospeciation between virus isolates and their primate hosts

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

The origin and evolution of hepatitis viruses in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Phylogenetic analysis of GBV-C/hepatitis G virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GBV-C/HGV genotypes: proposed nomenclature for genotypes 1-5.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Homologous recombination in GB virus C/hepatitis G virus

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Biophysical characterization of GB virus C from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Visualization and characterization of GB virus-C particles: evidence for a nucleocapsid

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Association of circulating hepatitis G virus with lipoproteins for a lack of binding with antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Identification of hepatitis G virus particles in human serum by E2-specific monoclonal antibodies generated by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Evaluation of four PCR systems amplifying different genomic regions for molecular diagnosis of GB virus C infections

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

An ELISA for detection of antibodies to the E2 protein of GB virus C.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Detection of antibodies to a putative hepatitis G virus envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Direct evidence for GB virus C/hepatitis G virus (GBV-C/HGV) superinfection: elimination of resident viral strain by donor strain in a patient undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

The GB virus C/hepatitis G virus replicates in hepatocytes without causing liver disease in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Analysis of hepatitis G virus/GB virus C quasispecies and replication sites in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Existence of distinct GB virus C/hepatitis G virus variants with different tropism

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Exposure to GB virus type C or hepatitis G virus in selected Australian adult and children populations.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Analysis of hepatitis G virus infection markers in blood donors and patients with hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

High prevalence of GB virus C/hepatitis G virus in healthy persons in Ho Chi Minh City, Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence and genotype of hepatitis G virus in Chinese professional blood donors and hepatitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

High prevalence of hepatitis G viremia among kidney transplant patients in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence of hepatitis G virus RNA in French blood donors and recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

High prevalence of GB-C/hepatitis G virus in a Brazilian population with helminth infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans?

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence of hepatitis G virus RNA in a monocentric population of French haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Viremia, genetic heterogeneity, and immunity to hepatitis G/GB-C virus in multiply transfused patients with thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Infection with GB virus C/hepatitis G virus in Brazilian hemodialysis and hepatitis patients and asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis GB virus C in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence of hepatitis G virus infection in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence patterns and genotypes of GB Virus C/hepatitis G virus among imprisoned intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence of GBV-C/hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GBV-C/HGV infection in children with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Influence of GB virus C viraemia on the clinical, virological and histological features of early hepatitis C-related hepatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Clinical implications of GB virus C.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GB virus-C infection in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Effect of coinfection with GB virus C on survival among patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Effects of co-infection with hepatitis C virus and GB virus C on CD4 cell count and HIV-RNA level among HIV-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

No evidence of benefical effect of GB virus type C infection on the course of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GB virus C genotype determination in GB virus-C/HIV co-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Molecular evidence for transmission of hepatitis G virus by blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Infection with hepatitis GB virus C in patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Infection with hepatitis G virus in immunoglobulin recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus in intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Infection with hepatitis G virus among recipients of plasma products

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus in clotting factor concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Mechanism of vertical transmission of hepatitis G

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Genetic evidence for mother-to-infant transmission of hepatitis G virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Evidence for probable sexual transmission of the hepatitis g virus

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Detection of GB virus C/hepatitis G virus in semen and saliva of HIV type-1 infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Transfusion-associated or nosocomial hepatitis G virus infection in patients undergoing surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

The risk of hospital-acquired GB virus C infection: a pilot case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence and disease association of hepatitis G virus infection in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Detection of hepatitis G virus (HGV) RNA: clinical characteristics of acute HGV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Acute sporadic non-A, non-B hepatitis in Northeastern Brazil: etiology and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Association between fulminant hepatic failure and a strain of GBV virus C.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis GB virus C.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GBV-C in the aetiology of fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GBV-C virus and fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Does GBV-C cause fulminant hepatitis in Japan?

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Infection with GB virus C (GBV-C) in patients with fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral, hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus infection in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence of GBV-C and hepatitis G virus variants in patients with fulminant hepatic failure in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus infection in acute fulminant hepatitis: prevalence of HGV infection and sequence analysis of a specific viral strain

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Possible association between serum GB virus C RNA level and disease activity in fulminant hepatitis type G.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prospective follow-up of patients with GBV-C/HGV infection: specific mutational patterns, clinical outcome, and genetic diversity

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus infection: clinical characteristics and response to interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Fulminant hepatic failure in a pediatric patient with active GB virus C (GBV-C)/hepatitis G virus (HGV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Histopathologic impact of GB virus C infection on chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Infection with GB virus C in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Effect of interferon on GB virus C and hepatitis C virus in hepatitis patients with the co-infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Influence of hepatitis G virus infection on liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

The clinical significance of GBV-C/HGV exposure in C-viral chronic liver disease and blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Clinical, virological, immunological, and pathological significance of GB virus C/hepatitis G infection in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

A study on pathogenicity of hepatitis G virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Poor association of GBV-C viremia with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Assessment of liver disease and biochemical and immunological markers in Swedish blood donors with isolated GB virus C/hepatitis G virus viremia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus does not cause significant liver disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Lack of anti-GOR antibody among subjects with GB virus C/hepatitis G virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GBV-C/HGV is not the major cause of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G-associated aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Aplastic anaemia after HGV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus infection as a possible causative agent of community-acquired hepatitis and associated aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Fulminant hepatitis in aplastic anemia: hepatitis G or ALG?

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis-associated aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Prevalence of GBV-C/HGV, a novel 'hepatitis' virus, in patients with aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis-associated aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis GB virus C genome in the serum of aplastic anaemia patients receiving frequent blood transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GBV-C/HGV infection and aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus in long-term survivors of haematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

HCV and HGV in B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus in patients with Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G virus infection in lymphoma and in blood donors.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

No association between hepatitis C and B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

Hepatitis G and mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GB virus C infection in patients with type II mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GBV-C/HGV and HCV infection in mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

HCV/HGV coinfection and cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2803%2900095-8

7 January 2021

GB virus C/hepatitis G virus replicates in human haematopoietic cells and vascular endothelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1099/0022-1317-82-11-2837

Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California

163

1 reference

https://api.crossref.org/works/10.1016/S1246-7820(03)00095-8

Could HGV infection be implicated in lymphomagenesis?

22 March 2024

188

1 reference

https://api.crossref.org/works/10.1016/S1246-7820(03)00095-8

Hepatitis G virus (HGV) and lymphoproliferative disorders

22 March 2024

191

1 reference

https://api.crossref.org/works/10.1016/S1246-7820(03)00095-8

22 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14563418%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference